Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities:
Net Income	$ 1,057.7	$ 592.3
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization of right-of-use assets	98.1	106.4
Amortization of intangible assets	59.8	62.4
Amortization of net deferred gain on interest rate swaps	(10.2)	(6.8)
Share-based compensation	57.8	52.5
Gain on disposition of subsidiary	(50.5)	0.0
COVID-19 repositioning costs	0.0	277.9
Other, net	36.6	50.6
Use of operating capital	(1,010.7)	(1,796.7)
Net Cash Provided By (Used In) Operating Activities	238.6	(661.4)
Cash Flows from Investing Activities:
Capital expenditures	(42.6)	(50.0)
Acquisition of businesses and interests in affiliates, net of cash acquired	(25.9)	(65.4)
Proceeds from disposition of subsidiaries and other, net	116.6	6.3
Net Cash Provided By (Used In) Investing Activities	48.1	(109.1)
Cash Flows from Financing Activities:
Proceeds from borrowings	791.7	1,186.6
Repayment of debt	(1,250.0)	(600.0)
Change in short-term debt	6.7	13.7
Dividends paid to common shareholders	(443.0)	(422.7)
Repurchases of common stock	(273.2)	(219.1)
Proceeds from stock plans	8.5	3.1
Acquisition of additional noncontrolling interests	(6.3)	(16.9)
Dividends paid to noncontrolling interest shareholders	(69.8)	(57.7)
Payment of contingent purchase price obligations	(16.8)	(25.4)
Other, net	(86.2)	(49.1)
Net Cash Used In Financing Activities	(1,338.4)	(187.5)
Effect of foreign exchange rate changes on cash and cash equivalents	(117.6)	(69.4)
Net Decrease in Cash and Cash Equivalents	(1,169.3)	(1,027.4)
Cash and Cash Equivalents at the Beginning of Period	5,600.5	4,305.7
Cash and Cash Equivalents at the End of Period	$ 4,431.2	$ 3,278.3